Plus Therapeutics Inc. (PSTV)
NASDAQ: PSTV
· Real-Time Price · USD
0.63
0.09 (16.19%)
At close: Aug 15, 2025, 3:59 PM
0.57
-9.98%
After-hours: Aug 15, 2025, 07:58 PM EDT
Plus Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.34M | 2.96M | 4.27M | 5.51M | 6.08M | 4.41M | 3.32M | 2.08M | 224K | 224K | n/a | n/a | n/a | n/a | n/a | n/a | 185K |
Cost of Revenue | 615K | 620K | 802K | 758K | 744K | 558K | 663K | 475K | 452K | 589K | 419K | 437K | 366K | 318K | 1.3M | 1.61M | 1.85M |
Gross Profit | -616K | -3K | 1.13M | 2.18M | 5.34M | 3.85M | 2.65M | 1.6M | -228K | -365K | -419K | -437K | -366K | -318K | -1.3M | -1.61M | -1.66M |
Operating Income | -14.93M | -14.7M | -14.65M | -14.11M | -11.9M | -13.32M | -15.04M | -16.88M | -20.51M | -19.71M | -18.08M | -16.48M | -13.94M | -12.49M | -11.95M | -9.85M | -9.62M |
Interest Income | 202K | 273K | 329K | 368K | 421K | 400K | 363K | 292K | 191K | 147K | 80K | 37K | 22K | 19K | 16K | 13K | 18K |
Pretax Income | -27.12M | -12.98M | -12.88M | -13.23M | -11.77M | -13.32M | -15.16M | -17.16M | -20.96M | -20.27M | -18.77M | -17.28M | -14.79M | -13.4M | -12.83M | -10.84M | -9.87M |
Net Income | -27.12M | -12.98M | -12.88M | -13.23M | -11.77M | -13.32M | -15.16M | -17.16M | -20.96M | -20.27M | -18.77M | -17.28M | -14.79M | -13.4M | -12.83M | -10.84M | -9.87M |
Selling & General & Admin | 10.38M | 9.94M | 9.19M | 8.79M | 8.51M | 8.55M | 9.75M | 9.98M | 10.34M | 10.24M | 8.69M | 8.46M | 7.64M | 6.85M | 7.11M | 6.18M | 6.14M |
Research & Development | 9.57M | 10.58M | 11.19M | 10.82M | 9.47M | 9.69M | 9.03M | 9.49M | 10.9M | 9.7M | 9.41M | 7.96M | 6.23M | 5.57M | 4.82M | 3.67M | 3.67M |
Other Expenses | -4.15M | -4.15M | -2.73M | -1.28M | n/a | n/a | 73K | 73K | 73K | 73K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 12.91M | 13.29M | 14.38M | 16.48M | 17.62M | 18.05M | 18.86M | 19.53M | 21.31M | 20.01M | 18.1M | 16.42M | 13.87M | 12.43M | 11.93M | 9.85M | 9.81M |
Interest Expense | 7.45M | 3.72M | 3.73M | 3.75M | 295K | 395K | 492K | 578K | 647K | 711K | 776K | 835K | 883K | 932K | 961K | 982K | 1M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -314K | -214K | -110K |
Cost & Expenses | 15.99M | 16.37M | 17.64M | 18.34M | 17.98M | 18.24M | 18.86M | 19.54M | 21.31M | 20.01M | 18.15M | 16.48M | 13.94M | 12.49M | 11.95M | 9.85M | 9.81M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 14.57M | 7.87M | 7.86M | 6.5M | 4.32M | 4.5M | 3.23M | 2.51M | 2.32M | 26.26M | 1.83M | 1.48M | 1.43M | 12.09M | 884.28K | 753.12K | 551.19K |
Shares Outstanding (Diluted) | 14.57M | 5.9M | 7.86M | 10.74M | 4.32M | 4.5M | 3.23M | 2.51M | 2.32M | 26.26M | 1.83M | 1.48M | 1.43M | 12.09M | 884.28K | 753.12K | 551.19K |
EPS (Basic) | -2.11 | -1.67 | -2.41 | -3.04 | -3.18 | -4.5 | -6.22 | -8.07 | -11.04 | -11.82 | -13.31 | -14.67 | -14.83 | -16.91 | -22.88 | -24.56 | -27.65 |
EPS (Diluted) | -2.77 | -2.33 | -2.67 | -3.3 | -3.18 | -4.5 | -6.22 | -8.07 | -11.04 | -11.82 | -13.29 | -14.65 | -14.81 | -16.89 | -22.88 | -24.56 | -27.65 |
EBITDA | -18.95M | -8.53M | -8.47M | -8.83M | -10.85M | -12.29M | -13.82M | -15.8M | -19.55M | -18.85M | -17.45M | -15.94M | -13.48M | -12.08M | -11.51M | -9.5M | -8.51M |
EBIT | -19.72M | -9.31M | -9.16M | -9.47M | -11.48M | -12.92M | -14.67M | -16.59M | -20.32M | -19.56M | -18M | -16.44M | -13.91M | -12.47M | -11.87M | -9.85M | -8.87M |
Depreciation & Amortization | 718K | 723K | 685K | 641K | 627K | 628K | 722K | 758K | 735K | 720K | 690K | 553K | 479K | 395K | 359K | 357K | 360K |